Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells.
about
Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the LiteratureConformational changes in DNA upon ligand binding monitored by circular dichroismCitrullination as early-stage indicator of cell response to single-walled carbon nanotubesCharacterization of novel synthesized small molecular compounds against non-small cell lung cancer.HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.Benzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cells.Hyaluronan-cisplatin conjugate nanoparticles embedded in Eudragit S100-coated pectin/alginate microbeads for colon drug deliveryRole of Bcl-2 family proteins and caspases in the regulation of apoptosis.Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity.Evaluation of antagonistic effects of metformin with Cisplatin in gastric cancer cells.Increasing the cisplatin cytotoxicity and cisplatin-induced DNA damage by conferone in 5637 cells.SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell.Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells.TIM-3 as a molecular switch for tumor escape from innate immunity.Development of pH-sensitive pectinate/alginate microspheres for colon drug delivery.Speciation in Metal Toxicity and Metal-Based Therapeutics.Radical multimodality therapy for malignant pleural mesothelioma.The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma.ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple-negative breast cancer cells
P2860
Q26766244-9742B39D-C1F6-4457-A312-B4FEF785FE07Q27026184-E3B456B1-D5C4-4994-B606-1BC65FFC866FQ28393563-0D1F7BA4-C13D-49ED-B83F-317C5D29C909Q30429640-814363FC-4538-45EC-AAA4-6EFF2DFBE477Q33841141-5A898A10-A665-4E33-8F12-E3B3DA1D4E20Q34227661-DD3C350A-EF96-43F2-996D-A94E5CD3E352Q35093497-204F878D-956F-42D7-A34D-F1C2A37C05C5Q36992149-A5D8C828-0B95-4E99-8849-33F8B88C8B90Q37826384-A7776ACD-08D8-4397-8E03-C7C9D9D40135Q38275446-C573DE16-0DEA-435D-822C-93E4968FA8BBQ38914047-5A06D1F5-42CB-4ECA-B107-07A93EF08CFCQ39459998-F5D6E387-1289-4E95-8AC8-A9C0838263E6Q39574549-7E693EEE-ABE2-4B4B-B503-4DBC9F16CBD5Q40969867-7E11D019-6798-4AC4-B6AA-5D7DE8F69B34Q42583763-9E237DD0-6190-46FC-AB06-5F46F1BC3542Q45034737-B03518DE-15F3-4AAC-BA39-BFC695BACDB0Q46737692-7C1B3452-B74C-42E9-BB8C-C61A8E2A1905Q47197708-B86C283D-6377-487E-B12E-25168EDCADA2Q55335738-D4912BCA-FD19-4FE2-8AD1-691C701FD820Q58699999-C70FB390-3902-4744-8746-14199A847BEB
P2860
Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@ast
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@en
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@nl
type
label
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@ast
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@en
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@nl
prefLabel
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@ast
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@en
Participation of Omi Htra2 ser ...... n on SW480 colon cancer cells.
@nl
P2093
P2860
P1476
Participation of Omi Htra2 ser ...... in on SW480 colon cancer cells
@en
P2093
Lizarraga F
Maldonado V
Melendez-Zajgla J
P2860
P304
P356
10.1179/JOC.2008.20.3.348
P577
2008-06-01T00:00:00Z